Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin Alfa Dosing in Pediatric CKD Anemia
NCT00436748Phase 3Terminated
- Sponsor
- Amgen
- Start
- Sep 2008
- Primary completion
- Mar 2014
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 10
01
Overview
A Phase 3 trial of darbepoetin alfa in anemia, sponsored by Amgen. Started Sep 2008; status: terminated.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00436748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00436748.